Pulse Biosciences, Inc. (PLSE)
47.90
-1.93
(-3.87%)
USD |
NASDAQ |
Oct 02, 16:00
47.91
+0.01
(+0.02%)
After-Hours: 20:00
Pulse Biosciences Profit Margin (Quarterly) : -5.68K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.68K% |
| March 31, 2026 | -4.63K% |
| December 31, 2025 | -6.60K% |
| September 30, 2025 | -22.54K% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -5.28K% |
| March 31, 2022 | -3.89K% |
| December 31, 2021 | -1.83K% |
| September 30, 2021 | -2.49K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Lucid Diagnostics, Inc. | -792.9% |
| Accuray, Inc. | -1.92% |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 27.82% |
| Neogen Corp. | -5.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -90.23% |
| Return on Assets | -76.64% |
| Return on Invested Capital | -83.18% |
| Gross Profit Margin (Quarterly) | 37.10% |
| Operating Margin (Quarterly) | -5.82K% |
| Return on Net Operating Assets | -747.1% |